- Home
- Publications
- Publication Search
- Publication Details
Title
CSF Penetration by Antiretroviral Drugs
Authors
Keywords
Ritonavir, Indinavir, Nelfinavir, Abacavir, Lopinavir
Journal
CNS DRUGS
Volume 27, Issue 1, Pages 31-55
Publisher
Springer Nature
Online
2012-12-18
DOI
10.1007/s40263-012-0018-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lower than expected maraviroc concentrations in cerebrospinal fluid exceed the wild-type CC chemokine receptor 5-tropic HIV-1 50% inhibitory concentration
- (2012) David Croteau et al. AIDS
- Determinants of darunavir cerebrospinal fluid concentrations
- (2012) Andrea Calcagno et al. AIDS
- Therapeutic Amprenavir Concentrations in Cerebrospinal Fluid
- (2012) David Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Low Cerebrospinal Fluid Concentrations of the Nucleotide HIV Reverse Transcriptase Inhibitor, Tenofovir
- (2012) Brookie M. Best et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Etravirine concentrations in CSF in HIV-infected patients
- (2012) J. M. Tiraboschi et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage
- (2011) Andrea Calcagno et al. AIDS
- Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research
- (2011) Lucette A Cysique et al. BMC Neurology
- Neurocognitive dysfunction in the highly active antiretroviral therapy era
- (2011) Nomvuyo Z. Mothobi et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study)
- (2011) M Saumoy et al. HIV MEDICINE
- CNS effects of a CCR5 inhibitor in HIV-infected subjects: a pharmacokinetic and cerebral metabolite study
- (2011) L. Garvey et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- 96 week results from the MONET trial: a randomized comparison of darunavir/ritonavir with versus without nucleoside analogues, for patients with HIV RNA
- (2011) N. Clumeck et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden
- (2011) Serena Spudich et al. JOURNAL OF INFECTIOUS DISEASES
- HIV and Age Do Not Substantially Interact in HIV-Associated Neurocognitive Impairment
- (2011) L. A. Cysique et al. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
- Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression
- (2011) Lucette A. Cysique et al. JOURNAL OF NEUROVIROLOGY
- Survival after neuroAIDS: Association with antiretroviral CNS Penetration-Effectiveness score
- (2011) E. Lanoy et al. NEUROLOGY
- Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients
- (2011) N. Ciccarelli et al. NEUROLOGY
- Maraviroc-containing regimen suppresses HIV replication in the cerebrospinal fluid of patients with neurological symptoms
- (2010) Giovanna Melica et al. AIDS
- Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort
- (2010) Marlene Smurzynski et al. AIDS
- Total Raltegravir Concentrations in Cerebrospinal Fluid Exceed the 50-Percent Inhibitory Concentration for Wild-Type HIV-1
- (2010) D. Croteau et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy
- (2010) Ana Canestri et al. CLINICAL INFECTIOUS DISEASES
- Neuropsychiatric Adverse Events With Ritonavir-Boosted Darunavir Monotherapy in HIV-Infected Individuals: A Randomised Prospective Study
- (2010) Alan Winston et al. HIV CLINICAL TRIALS
- Maraviroc Concentrations in Cerebrospinal Fluid in HIV-Infected Patients
- (2010) Juan Manuel Tiraboschi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Efavirenz concentrations in CSF exceed IC50 for wild-type HIV
- (2010) B. M. Best et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors
- (2010) Robert K. Heaton et al. JOURNAL OF NEUROVIROLOGY
- Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort
- (2010) K. R. Robertson et al. NEUROLOGY
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study
- (2010) R. K. Heaton et al. NEUROLOGY
- Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection
- (2010) Lars Hagberg et al. AIDS Research and Therapy
- HIV, the brain, children, HAART and ‘neuro-HAART’: a complex mix
- (2009) Bruce J Brew AIDS
- Cerebrospinal fluid maraviroc concentrations in HIV-1 infected patients
- (2009) Aylin Yilmaz et al. AIDS
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- Impact of HAART and CNS-penetrating antiretroviral regimens on HIV encephalopathy among perinatally infected children and adolescents
- (2009) Kunjal Patel et al. AIDS
- Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course
- (2009) Patrick R Harrington et al. AIDS
- Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1–Infected Individuals
- (2009) Aylin Yilmaz et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Lopinavir Cerebrospinal Fluid Steady-State Trough Concentrations in HIV-Infected Adults
- (2009) Robert DiCenzo et al. ANNALS OF PHARMACOTHERAPY
- The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research
- (2009) Lavanya Varatharajan et al. ANTIVIRAL RESEARCH
- Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy
- (2009) Aylin Yilmaz et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis
- (2009) Jose R Arribas et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders
- (2009) Valerio Tozzi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy
- (2009) L. A. Cysique et al. NEUROLOGY
- Raltegravir Cerebrospinal Fluid Concentrations in HIV-1 Infection
- (2009) Aylin Yilmaz et al. PLoS One
- Low atazanavir concentrations in cerebrospinal fluid
- (2008) Brookie M Best et al. AIDS
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- A Review of the Pharmacokinetics of Abacavir
- (2008) Geoffrey J Yuen et al. CLINICAL PHARMACOKINETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started